\"

Post-Conference Workshop - Thursday, 22nd September

Workshop B

09:00 AM - 12:00 PM Leveraging Databases and Technology for the Detection and Management of Safety Signals

Jamal Baig, Associate Director of Pharmacovigilance, Merck Sharp And Dohme (MSD)
Data-mining during all stages of drug development: from drug discovery to best practices in post-marketing surveillance

  • Converting ICSRs into structured formats and evaluating if a signal should be investigated
  • Examining aggregate reports periodically to identify signals not detected from individual data
  • Revising your safety monitoring practices to changing regulatory standards
  • Compare and contrast existing PV databases: how can you ensure quality?

img

Jamal Baig

Associate Director of Pharmacovigilance
Merck Sharp And Dohme (MSD)